Logo
x

Search category

Subscribe Now

Immuno-oncology Portfolio

Boehringer Ingelheim Acquires Northern Biologics' Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio

Boehringer Ingelheim Acquires Northern Biologics' Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio

  • May 15, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.